The Importance of HbA1c Reduction in Adult Type 2 Diabetes
September 23 @ 7:00 pm – 8:45 pm
Promotional meeting supported and funded by A. Menarini Farmaceutica Internazionale SRL for UK registered HCPs only.
Join us for this promotional webinar covering an overview of the latest updates in diabetes management, including the 2026 NG28 clinical categories, updated guidance, and HbA1c targets. The session will also explore the importance of early HbA1c reduction in lowering long-term risk, alongside the evolving role of early SGLT2i therapy in improving patient outcomes.
AGENDA
7.00pm Welcome and Registration – Jim Tullie – HCP Ed-UK Meeting Facilitator
7.10pm Speakers: Meredith Donaldson & Prof Raj Thakkar
Talking Points
- T2D Complications
- New clinical categories in the NG28 2026 update
- HbA1c Targets
- Importance of HbA1c Reduction to reduce T2D risk
- The importance of early SGLT2i initiation
- Case studies
8.15pm Q&A
8.45pm Meeting summary & close
Supported and funded by A. Menarini Farmaceutica Internazionale SRL including honoraria in accordance with the ABPI code of practice. June 2026 | PP-IN-UK-3455
To download a copy of the full agenda click here
